A new noise reducing cabinet for the PT-TD300 tapped density and apparent density testing instrument is optionally available. The new cabinet reduces noise inherent to the tapping mechanism of the instrument by up to 10 decibel down to 62 decibel compared to using the instrument without a cabinet (both measured at the same distance – […]
Achievement Demonstrates OpenEye’s Unparalleled Experience Helping Pharmaceutical and Biotechnology Customers Optimize Computing Workloads SANTA FE, N.M. – OpenEye Scientific, developer of the world’s only cloud-native molecular design platform, Orion,™ announced today that it is among the first of only a handful of companies globally that have achieved Amazon Web Services (AWS) High Performance Computing (HPC) Competency status. […]
Achievement Demonstrates OpenEye’s Unparalleled Experience Helping Pharmaceutical and Biotechnology Customers Optimize Computing Workloads SANTA FE, N.M. – OpenEye Scientific, developer of the world’s only cloud-native molecular design platform, Orion,™ announced today that it is among the first of only a handful of companies globally that have achieved Amazon Web Services (AWS) High Performance Computing (HPC) Competency status. […]
Cambridge, UK – Cresset, innovative provider of computational solutions and services for small molecule drug discovery and design, is pleased to announce the appointment of David Newble as Non-Executive Director. “I’m delighted to welcome David to the Cresset Board to advise and contribute to the continued growth of the company,” says Dr Robert Scoffin, CEO, […]
Orion™ Molecular Design Platform Helps Pharmaceutical, Biotechnology Companies Better Identify, Optimize, and Order Hits and Leads from Mcule’s database SANTA FE, N.M., & PALO ALTO, Calif. – OpenEye Scientific and Mcule – a leading online marketplace for drug discovery – today announced that OpenEye’s Orion™ molecular design platform now can greatly enhance the ability to […]
CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the appointment of Dr Rae Lawrence as Director of Software Development. With the continued success of the Company’s portfolio of cheminformatics and AI-based drug discovery software, and the recent backing by Kester Capital, Optibrium has made the new appointment to drive its product development […]
Investment by Kester Capital will drive commercial growth and the development of new products to improve speed, efficiency, and productivity of the discovery process CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced it has raised significant investment from Kester Capital, a leading UK mid-market private equity firm typically investing between £10 to […]
Sygnature Accelerates Customers’ Drug Discovery Timelines with Improved Hit Identification, Lead Optimization Capabilities SANTA FE, N.M., USA, & NOTTINGHAM, UK – 21 January 2021 – OpenEye Scientific and Sygnature Discovery – a world-leading integrated discovery and pre-clinical solutions provider – today announced the adoption of OpenEye’s Orion™ platform to power Sygnature’s computational efforts in molecular design drug […]
DeepMatter Group plc, the AIM-quoted company focusing on digitising chemistry, is pleased to announce that one of its wholly owned subsidiaries has entered into a multi-year, limited-use data licensing agreement with the Life Science business of Merck to provide proprietary chemical structure and reaction data content to Merck’s selected application. Merck, a leading science and […]
New features include reaction-based library enumeration for novel molecule generation and optimisation AI-integrated with seamless interface to Optibrium’s Artificial Intelligence platform, Cerella, to extract greater value from drug discovery data CAMBRIDGE, UK: Optibrium™, a developer of software for drug discovery, today announced the release of the newest version of StarDrop™, a comprehensive software platform for small […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
